CRISPR, which is short for Clustered Regularly Interspaced Short Palindromic Repeats, are segments of DNA containing repetitive base sequences. A simple version of CRISPR, known as CRISPR/Cas9 has been modified to allow addition or removal of genes, so editing the genome of a cell. This ability to edit a genome is a big deal, and not surprisingly was the choice of Science magazine for the Breakthrough of the Year in 2015.
Not surprisingly with such a potentially important invention, there have been disputes over ownership. In particular there has been a high profile dispute between the Broad Institute (MIT) and University of California. This was recently decided in that the USPTO declared that the patents did not interfere with each other, i.e. were separate inventions.
Now that this case is over, it may be worth asking - who else is filing similar and important patents in this space?
This listing is summarized in the graph below - for more details, read here.